..Information to Pharmacists
    _______________________________

    Your Monthly E-Magazine
    NOVEMBER, 2002

    Published by Computachem Services

    P.O Box 297.
    Alstonville. 2477
    NSW Australia

    Phone:
    61 2 66285138

    E-Mail
    This
    Page
    Click For a
    Printer-Friendly
    Page
    Bookmark
    This Page

    PETER ALLEN

    Community Pharmacist Perspective

    Postcards From the Coalface

    Editor's Note: Some people have all the luck. Terry Irvine, who usually writes under this title, is currently roughing it on a tour of Europe, so Peter Allen has taken over for this edition.
    Peter is a Melbourne community pharmacist, who is one of the more prolific contributors to Auspharmlist, where his various topics are well written, well organised and often delivered with a sense of pungency. He is also a contributor to the www.auspharmacist.net site.
    Peter is a welcome addition to our team.
    His topic for this article covers some attitudinal aspects of global drug manufacturers.

    Not good enough, Mr Schering-Plough, Elocon cream and ointment being out of stock for about a month altogether, and no close replacement available.

    Knowing the reason for the prolonged out-of-stock position (not a strike at the mine nor an Act of God, no, it's time to re-decorate the factory! -- so in no way unforseen).
    I reckon it's time for manufacturers to do their bit in this "Risk-Sharing" environment that pharmacists have been 'offered' in the PBS i.e we do more scripts we get less / we do less we get more.
    I'd like those odds for the Melbourne Cup!

    In the drug company's board room, the decision is made: the word is economic rationalism -- we close half of the factories around the world, they're redundant, and we'll just minimise our risk of being out of stock
    by finding duplicate sources of materials, installing better surveillance against catastrophes, put in a fire engine at the French's Forest plant, move the factory from the earthquake fault line in Japan, and should there be some unforeseen setback, though there will be some lost sales, the customers will eventually come back to us..
    The shareholders will be happy and that's why we're here.
    And when the plant comes back online, do we fly stocks out to California, where it retails for US$24 (www.drugstore.com price) or send it to the wrong side of the world, where it wholesales for A$5.15? Golly that's a hard one.

    I know, I have a friend in that job, he came from Chemical Engineering, and they call it Risk Management.

    And it's win-win all the way for Mr Schering-Plough.
    How about we plough up the playing field to level it?

    One suggestion for consideration:
    The HIC reduce the price to manufacturer in the next Yellow Book on a sliding scale...the longer the product is out of stock (beyond say a fortnight ) the bigger the clawback.

    Editor's Note: This is also happening for emergency drugs in hospitals. Recently, Parvolex injections disappeared from the shelves, with the promise of a one month wait. Now the month is up, and there is an inability for the manufacturer to give a date for supply. Parvolex is used in the emergency departments of hospitals for paracetamol poisoning.


    Back to Front Page